CPEARL Program Awardee Responsibilities

Investigators awarded funding from the Translational Research Institute (TRI) must adhere to the following responsibilities:

Orientation: Awardees must attend an orientation session that reviews TRI’s expectations, available resources, and adherence to federal regulations and NIH policies.

Compliance: The award recipient and other project staff must comply with the Heath Insurance Portability and Accountability Act (45 C.F.R. Parts 160 and 164) and other research and confidentiality requirements described in UAMS’ Administrative Guide.

Regulatory Approval: Prior to receiving funds and initiating research activities, the award recipient must obtain all necessary regulatory approvals (e.g., Institutional Review Board, Department of Occupational Health and Safety). Documentation of applicable approvals will be required before funds are disbursed.

Accounting and Audit: Accounting policies for the project will be consistent with those for the UAMS campus. All expenses must be allowable under the provisions of all applicable OMB Circulars, State of Arkansas procurement regulations, and UAMS standards and be consistent with the project’s budget. All financial records relating to TRI awards are subject to Arkansas Legislative and OMB A-133 audit. If requested the award recipient must be able to describe the nature of project expenses and establish the relatedness of the expenses to the project and establish the relatedness of the expenses to the project.

Limitation on Costs: The TRI through UAMS is not, in the absence of a modification, obligated to reimburse costs incurred in excess of the approved budget of the award amount.

Supplanting: Funds received may not be used to supplant other funds available to the award recipient. If TRI becomes aware of supplanting, funding for the project will be terminated. Furthermore, supplanting violations may result in suspension of future funds and recoupment of monies provided under TRI’s funding programs.

Publicity/Citation Language: The PI must acknowledge support of TRI and the appropriate award number as the funding source in any news releases, articles, or publications relating to the funded project or its results. Furthermore, a copy of any such materials must be provided to TRI. Failure to properly acknowledge TRI may result in the PI being ineligible to receive future support from any TRI program. You can find more specific information about how to properly cite TRI by visiting our Cite TRI page.

Public Access Compliance: All publications must also abide by the NIH Public Access Policy found at: http://publicaccess.nih.gov/index.htm

Dissemination: Within 1 year of award completion, awardees are required to 1) present their study results at the annual CTSA conference and 2) develop a dissemination infographic in lay language that will be shared with lay audiences and community stakeholders.

Project Suspension: The grant may be suspended in whole or in part by:

  1. TRI on written notice to the award recipient if the award recipient has materially failed to comply with the terms and conditions of the award as outlined herein and as identified in the approved application;
  2. TRI and award recipient by written agreement; or
  3. award recipient on written notice to TRI setting forth the reasons for such action, the effective date, and, in the case of partial suspension, the portion to be suspended.

Suspension of the award may include discontinuation of payments to award recipient by TRI and/or discontinuation of further spending of funds by award recipient. The award recipient agrees to comply with the directions of TRI regarding the unexpended award funds when the grant is suspended.